2026-11-01
In medical device lifecycle management, managing discontinued high-performance equipment is a recurring challenge for clinical engineering departments. The Olympus UHI-2 high-flow insufflator remains in use at some facilities even though the manufacturer has formally ended production, creating maintenance and spare-parts questions for surgical programs that still rely on the device.
The Olympus UHI-2, also designated UHI2, is a high-flow carbon dioxide insufflator used in laparoscopic surgery. Its core function is to deliver carbon dioxide (CO2) insufflation at rates of up to 35 L/min to maintain stable pneumoperitoneum pressure.
The device also integrates smoke and mist evacuation, a function intended to preserve a clear intraoperative field and support surgical safety. For clinical teams, that combination of insufflation capacity and visualization support is central to the equipment’s continued relevance.
Although the manufacturer has officially discontinued the Olympus UHI-2, the model still has a role in clinical practice. For facilities that continue to use it, maintenance and spare-parts support are key to protecting surgical continuity.
Common management strategies for discontinued equipment include:
These approaches are intended to balance cost, downtime risk and clinical requirements until a replacement decision is made.
The published specifications for the UHI-2 are summarized below.
| Specification | Details |
|---|---|
| Device model | Olympus UHI-2 / UHI2 |
| Maximum insufflation flow | 35 L/min |
| Primary functions | CO2 insufflation, smoke and mist evacuation |
| Device status | Discontinued |
The model is no longer in production, though its flow capacity and smoke-evacuation functions remain part of the clinical rationale for keeping selected units in service.
For discontinued but still clinically useful devices such as the Olympus UHI-2, an active maintenance strategy is appropriate. Independent service providers with repair capabilities can offer evaluation and restoration support, helping facilities maximize equipment performance during the replacement cycle.
Device selection and maintenance decisions should consider repair-support capacity and the reliability of existing spare-parts inventories. Such planning allows clinical engineering teams to manage risk while continuing to meet surgical demand.